Average Co-Inventor Count = 12.95
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Aktiengesellschaft (11 from 12,165 patents)
2. The Broad Institute, Inc. (10 from 444 patents)
3. Bayer Pharma Aktiengesellschaft (9 from 378 patents)
4. Harvard College (6 from 2,971 patents)
5. The General Hospital Corporation (6 from 2,896 patents)
6. Dana-Farber-Cancer Institute Inc. (3 from 1,210 patents)
7. Bayer Aktiengellschaft (1 from 5 patents)
8. Bayer Pharma Aktiengellschaft (1 from 1 patent)
9. Bayer Pharma Aktiegellschaft (1 from 1 patent)
12 patents:
1. 12486248 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
2. 12427153 - 1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases
3. 12258323 - Dihydrooxadiazinones
4. 11787797 - 4,5-annulated 1,2,4-triazolones
5. 11773070 - Dihydrooxadiazinones
6. 11713304 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
7. 11427553 - Dihydrooxadiazinones
8. 11365179 - Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazolone
9. 11161825 - 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides
10. 11130745 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
11. 10968216 - 4,5-annulated 1,2,4-triazolones
12. 10815215 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH